New drug aims to heal hearts after major attack
Disease control
Not yet recruiting
This study tests a drug called NL005 in people who have had a severe type of heart attack (STEMI) and undergone emergency artery-opening treatment. The goal is to see if NL005 can reduce permanent heart muscle damage. Participants will receive either NL005 or a placebo daily for …
Phase: PHASE2 • Sponsor: Beijing Northland Biotech. Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC